卫宁健康上市14周年：归母净利润累计增长98.44%，市值较峰值蒸发60.66%

Core Insights - The main business of the company includes medical software research and development, sales, and technical services, providing comprehensive solutions for the healthcare industry [2] - The company's core products are primarily divided into software and services, which account for 77.33% of revenue, and internet healthcare, which accounts for 12.11% [2] - Since its listing in 2011, the company has achieved a cumulative net profit growth of 98.44%, reaching 0.88 billion yuan in the latest fiscal year 2024 [2] Revenue Analysis - In 2020, the company achieved a revenue of 2.267 billion yuan, which increased to 2.782 billion yuan in 2024, although a decline was noted in 2024 [3] Profit Analysis - The company's net profit attributable to shareholders was 491 million yuan in 2020, dropping to 88 million yuan in 2024, indicating significant volatility and an overall downward trend in profit levels [4] Market Performance - Since its IPO, the company's market value has increased by 9.02 times, demonstrating strong growth potential [6] - The peak market value reached 58.552 billion yuan on July 10, 2020, with the stock price rising to 27.44 yuan, but by August 15, the market value had decreased to 23.035 billion yuan, representing a loss of 35.517 billion yuan or 60.66% from its peak [6]